Results 31 to 40 of about 2,238 (188)

Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study. [PDF]

open access: yesTransfusion
BACKGROUND: Neonates with hemolytic disease of the fetus and newborn (HDFN) may require exchange transfusions (ET) for severe hyperbilirubinemia. We evaluated if ET in neonates with HDFN was associated with the maximum maternal titer and antibody ...
de Winter DP   +25 more
europepmc   +3 more sources

Understanding the consequences of being RhD immunized during pregnancy 10 years after introduction of targeted routine antenatal anti‐D prophylaxis: A retrospective nationwide cohort study [PDF]

open access: yesActa Obstetricia et Gynecologica Scandinavica
Introduction Targeted routine antenatal anti‐D prophylaxis (RAADP) was introduced in Finland in 2014. The aim of this study was to assess the prevalence of anti‐D immunizations among pregnant women and the severity of hemolytic disease of the fetus and ...
Anna Parhamaa   +8 more
doaj   +2 more sources

Severe Hemolytic Disease of the Fetus Treated with Serial Intrauterine Transfusions: A Case Report and Review of Current Management [PDF]

open access: yesLife
Hemolytic disease of the fetus and newborn (HDFN) is a severe complication of pregnancy caused by maternal alloimmunization to fetal red blood cells, leading to significant perinatal morbidity and mortality.
Olga Olejniczak   +2 more
doaj   +2 more sources

Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010AJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2023
BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) is mediated by maternal alloantibodies, a consequence of immune sensitization during pregnancy with maternal-fetal incompatibility with ABO, Rhesus factor (Rh), and/or other red blood cell ...
Devin Yu, PharmD   +4 more
doaj   +1 more source

Value of three hemolysis tests and carboxyhemoglobin in the diagnosis of hemolytic disease of the fetus and newborn

open access: yesZhongguo shuxue zazhi, 2023
Objective To investigate the value of three hemolysis tests and carboxyhemoglobin (COHb) level in the diagnosis of hemolytic disease of the fetus and newborn (HDFN).
Fan ZHAO   +7 more
doaj   +1 more source

Analysis of ABO system hemolytic disease of the fetus and newborn in 1 040 cases and its influencing factors

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze ABO system hemolytic disease of the fetus and newborn (HDFN) and its influencing factors in Obstetrics Department of our hospital.
Shuling DONG   +5 more
doaj   +1 more source

A Case of a Newborn With Blocked RhD Antigen and HDFN [PDF]

open access: yesLaboratory Medicine, 2017
A group O RhD-negative pregnant patient with anti-D antibody at titer 1:2048 delivered a baby boy by cesarean section at 38 + 6 weeks gestational age. The neonate typed as group O, but D antigen was at first uncertain. DAT and antibody screen of newborn were both positive. Various assays were used for D antigen determination.
Haijuan, Wang   +2 more
openaire   +2 more sources

History and current standard of postnatal management in hemolytic disease of the fetus and newborn [PDF]

open access: yes, 2023
Since the discovery of the Rh blood group system in 1940, a greater understanding of hemolytic disease of the fetus and newborn (HDFN) was gained. In the years thereafter, researchers and clinicians came to the current understanding that fetal and ...
Hulzebos, Christian   +5 more
core   +3 more sources

Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

open access: yesBMC Pregnancy and Childbirth, 2023
Background Advances in postnatal care for hemolytic disease of the fetus and newborn (HDFN) have occurred over the past decades, but little is known regarding the frequency of postnatal treatment and the clinical outcomes of affected neonates.
Derek P. de Winter   +4 more
doaj   +1 more source

Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape

open access: yesBMC Pregnancy and Childbirth, 2023
Background Prevention of pregnancy-related alloimmunization and the management of hemolytic disease of the fetus and newborn (HDFN) has significantly improved over the past decades. Considering improvements in HDFN care, the objectives of this systematic
Derek P. de Winter   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy